Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Br J Pharmacol ; 109(2): 510-7, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8358550

RESUMO

1. The goal of this study was to determine if an increase in cytoplasmic calcium concentration ([Ca2+]i), in the absence of additional second messengers derived from membrane phospholipid turnover, is a sufficient signal to induce chloride secretion across monolayers of the human colonic epithelial line, T84. 2. Thapsigargin was used to increase [Ca2+]i by inhibiting the endomembrane Ca(2+)-ATPase. [Ca2+]i was monitored in monolayers by fura-2 fluorescence spectroscopy, chloride secretion by measuring changes in short circuit current (Isc) in modified Ussing chambers, and inositol phosphates were measured by radio-h.p.l.c. of extracts of cells prelabelled with [3H]-inositol. 3. Thapsigargin increased [Ca2+]i and Isc in parallel, without increasing any inositol phosphates. The effect of thapsigargin on Isc was abolished by the intracellular calcium chelator, bis-(o-aminophenoxy)-ethane-N,N,N',N"-tetraacetic acid (BAPTA). 4. Increasing [Ca2+]i with thapsigargin did not prevent a subsequent calcium response to carbachol or histamine if extracellular calcium was available. In the absence of extracellular calcium, only one such release of calcium to hormonal stimulation occurred when cells were pretreated with thapsigargin, and a second response to either carbachol histamine was essentially abolished. 5. Addition of carbachol or histamine to thapsigargin-treated cells mounted in Ussing chambers caused a transient further increase in Isc followed by termination of the response, even though [Ca2+]i continued to rise. 6. We conclude that an elevation in [Ca2+]i is a sufficient signal to induce chloride secretion in T84 cells. Rather than being required to stimulate secretory responses, additional second messengers induced by hormonal secretagogues (such as inositol phosphates) may in fact serve to limit the secretory response.


Assuntos
Cálcio/farmacologia , Cloretos/metabolismo , Colo/metabolismo , ATPases Transportadoras de Cálcio/antagonistas & inibidores , Carbacol/farmacologia , Linhagem Celular , Colo/efeitos dos fármacos , Citosol/efeitos dos fármacos , Citosol/metabolismo , Epitélio/efeitos dos fármacos , Epitélio/metabolismo , Histamina/farmacologia , Humanos , Inosina Trifosfato/metabolismo , Fosfatos de Inositol/metabolismo , Fosfolipídeos/metabolismo , Terpenos/farmacologia , Tapsigargina
2.
Am J Physiol ; 264(5 Pt 1): C1210-8, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-8388632

RESUMO

Cl- secretion in T84 cells evoked by a stimulus that activates protein kinase C, carbachol, was associated with elevated levels of 32P-labeled phosphatidic acid (PA). PA's role in the regulation of Cl- secretion was explored by examining the effect of exogenous PA (10(-4) M) on Cl- secretion and intracellular Ca2+ levels ([Ca2+]i) in monolayers. PA potentiated the effect of carbachol on [Ca2+]i and Cl- secretion, although it did not stimulate Cl- secretion by itself. PA had divergent effects on cyclic nucleotide-dependent Cl- secretion. It delayed Cl- secretion induced by vasoactive intestinal polypeptide [VIP, adenosine 3',5'-cyclic monophosphate (cAMP) dependent] but potentiated that induced by the heat-stable enterotoxin of Escherichia coli (STa; guanosine 3',5'-cyclic monophosphate dependent). PA did not alter AMP or GMP levels, suggesting that PA acts at a site distal to the generation of these second messengers. PA caused a slight increase in phosphorylation of protein kinase C substrates but not of cAMP-dependent protein kinase substrates. However, PA is probably not acting through a classical protein kinase C pathway, because we have previously shown that phorbol esters inhibit carbachol's actions, and the protein kinase C inhibitor staurosporine failed to block the effect of PA on VIP- or STa-stimulated Cl- secretion. Thus PA differentially regulates stimulated Cl- secretion in T84 cells, depending on the nature of the agonist.


Assuntos
Cálcio/metabolismo , Cloretos/metabolismo , Fosfatos de Inositol/metabolismo , Ácidos Fosfatídicos/metabolismo , Ácidos Fosfatídicos/farmacologia , Fosfolipídeos/metabolismo , Carbacol/farmacologia , Cromatografia em Camada Fina , Neoplasias do Colo , AMP Cíclico/metabolismo , Citosol/metabolismo , Eletroforese em Gel Bidimensional , Eletroforese em Gel de Poliacrilamida , Humanos , Fosfatos de Inositol/isolamento & purificação , Cinética , Fosfatidilinositol 4,5-Difosfato , Fosfatidilinositóis/metabolismo , Fosfoproteínas/isolamento & purificação , Fosfoproteínas/metabolismo , Fosforilação , Células Tumorais Cultivadas , Peptídeo Intestinal Vasoativo/farmacologia
3.
Am J Physiol ; 262(1 Pt 1): C15-22, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1733229

RESUMO

Ca(2+)-dependent secretagogues (e.g., carbachol, histamine, ionomycin, and 4-bromo-A23187) have relatively transient effects on chloride secretion, even if there is a sustained increase in cytosolic calcium ([Ca2+]i) (as for the ionophores). Because these agents increase both [Ca2+]i and protein kinase C (PKC) activity, chloride secretion might be stimulated by [Ca2+]i and terminated by PKC activity. We tested the effect of a PKC activator, phorbol 12-myristate 13-acetate (PMA), on Cl- secretion by T84 cell monolayers by measuring short-circuit current (Isc). PMA alone had no effect on Isc but potentiated increases in Isc when added 10 min or less before Ca(2+)-dependent secretagogues. Chelation of [Ca2+]i with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibited the increases both in [Ca2+]i and Isc induced by carbachol with or without brief PMA pretreatment. Longer preincubations with PMA inhibited Isc responses to Ca(2+)-dependent secretagogues, even when increased [Ca2+]i was sustained by ionophores. Inhibitors of PKC could reverse the inhibitory effect of PMA but did not reverse the potentiating effect. The effects of PMA on Cl- secretion were reproduced by 1,2-dioctanoyl-sn-glycerol and were mirrored by effects on K+ channel opening. Thus PMA has dual effects on chloride secretion. Initially, it exerts a stimulatory action and subsequently an inhibitory action. The stimulatory effect only occurs if Ca(2+)-dependent secretion is ongoing. The inhibitory effect of PMA is mediated by PKC and cannot be overcome by increasing [Ca2+]i.


Assuntos
Cálcio/farmacologia , Cloretos/metabolismo , Colo/metabolismo , Mucosa Intestinal/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina , Alcaloides/farmacologia , Linhagem Celular , Colo/citologia , Humanos , Mucosa Intestinal/citologia , Isoquinolinas/farmacologia , Concentração Osmolar , Piperazinas/farmacologia , Inibidores de Proteínas Quinases , Rubídio/metabolismo , Esfingosina/farmacologia , Estaurosporina , Fatores de Tempo
7.
Am J Physiol ; 258(5 Pt 1): C902-12, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-2159233

RESUMO

The inflammatory mediator adenosine caused sustained Cl- secretion across monolayers of T84 cells. The effect was promptly reversed by the adenosine receptor antagonist 8-phenyltheophylline and appeared to be mediated through an adenosine A2-receptor [rank order of potency: 5'-(N-ethyl)-carboxamido-adenosine (NECA) greater than adenosine greater than (-)-N6-(phenylisopropyl)adenosine (PIA) greater than or equal to (+)-PIA]. High doses of adenosine and its analogues increased cellular adenosine 3',5'-cyclic monophosphate (cAMP) but not guanosine 3',5'-cyclic monophosphate (cGMP) or free cytosolic Ca2+. However, lower concentrations of adenosine had maximal effects on Cl- secretion with little or no effect on cAMP. In other respects, Cl- secretion resembled that induced by cAMP-mediated secretagogues such as vasoactive intestinal peptide (VIP). Addition of both low and high doses of NECA activated basolateral K+ and apical Cl- channels, exhibited synergism with Ca2(+)-mediated secretagogues, did not produce additive effects with VIP or Escherichia coli heat-stable enterotoxin, and was associated with cAMP-dependent protein kinase-mediated protein phosphorylation. The results suggest that either adenosine mobilizes an intracellular pool of cAMP that is extremely efficiently coupled to the cAMP-dependent protein kinase and is thereafter rapidly destroyed or that second messenger(s) other than cAMP, cGMP, or Ca2+ are able to activate Cl- secretion in the T84 cell line. In the latter case, such messenger(s), as yet unidentified, might represent a final common pathway for cyclic nucleotide-activated Cl- secretion.


Assuntos
Adenosina/análogos & derivados , Adenosina/farmacologia , Cloretos/metabolismo , 2-Cloroadenosina/farmacologia , Adenosina-5'-(N-etilcarboxamida) , Cálcio/metabolismo , Linhagem Celular , AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Citosol/metabolismo , Eletrólitos/metabolismo , Epitélio/efeitos dos fármacos , Epitélio/imunologia , Epitélio/metabolismo , Histamina/farmacologia , Humanos , Inflamação , Cinética , Fenilisopropiladenosina/farmacologia , Fosforilação , Proteínas Quinases/metabolismo , Teofilina/análogos & derivados , Teofilina/farmacologia
11.
Am J Physiol ; 257(6 Pt 1): G950-60, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2514601

RESUMO

Changes in cytosolic free Ca2+ ([Ca2+]i) in response to the secretagogue carbachol have been characterized in the human colon cancer cell line T84, a model Cl- secretory cell. In this study, [Ca2+]i was determined with the fluorescence indicator fura-2 at the single-cell level with a fluorescent microscope-imaging system. Basal [Ca2+]i in T84 cells in Ringer-HCO3 solution was 76 +/- 4 nM and was decreased by exposure to Ca2+ free solution or 25 microM verapamil. The cholinergic agonist carbachol caused a concentration-dependent rise in [Ca2+]i with a Km of 4 microM and a peak increase in [Ca2+]i of approximately 50 nM. The onset of the [Ca2+]i increase was within 3 s, occurred uniformly among cells, and peaked at 10-15 s. The increase in [Ca2+]i was heterogenous in the length of time the [Ca2+]i remained elevated above basal, and cell responses could be divided into at least two groups on that basis. Blocking the contributions of intracellular Ca2+ with dantrolene inhibited the increase in [Ca2+]i as early as could be determined, whereas blocking the extracellular contribution with ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), verapamil, or nifedipine inhibited a slightly later increase in [Ca2+]i. In conclusion, the initial detectable increase in [Ca2+]i caused by carbachol is due to the release of Ca2+ from internal stores, whereas the contribution of extracellular Ca2+ occurs later and at least partially involves a nifedipine- and verapamil-sensitive process.


Assuntos
Cálcio/metabolismo , Carbacol/farmacologia , Células Tumorais Cultivadas/metabolismo , Atropina/farmacologia , Linhagem Celular , Neoplasias do Colo , Citosol/efeitos dos fármacos , Citosol/metabolismo , Dantroleno/farmacologia , Ácido Egtázico/farmacologia , Humanos , Cinética , Microscopia de Fluorescência/instrumentação , Microscopia de Fluorescência/métodos , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/efeitos dos fármacos , Verapamil/farmacologia
13.
J Clin Invest ; 84(3): 945-53, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2547841

RESUMO

When applied to the basolateral (serosal) side of the T84 colonic epithelial monolayer, taurodeoxycholate caused net Cl- secretion in a dose-dependent manner with a threshold effect observed at 0.2 mM. In contrast, when applied to the apical (luminal) surface, concentrations of taurodeoxycholate below 1 mM had little or no effect. Only when the concentration of taurodeoxycholate present on the apical side was greater than or equal to 1 mM did apical addition results in an electrolyte transport effect. This apical effect on electrolyte transport was associated with an abrupt increase in the permeability of the monolayer. Cyclic AMP and cyclic GMP in the T84 monolayers were not increased by the bile salt, but in the presence of extracellular Ca2+, free cytosolic Ca2+ increased with a graded dose effect and time course that corresponded approximately to the changes in short circuit current (Isc). The results suggest that luminal bile salts at a relatively high concentration (greater than or equal to 1 mM) increase tight junction permeability. Once tight junction permeability increases, luminal bile salts could reach the basolateral membrane of the epithelial cells where they act to increase free cytosolic Ca2+ from extracellular sources. The resulting increases in free cytosolic Ca2+, rather than in cyclic nucleotides, appear to be involved in transcellular Cl- secretion.


Assuntos
Ácidos e Sais Biliares/farmacologia , Cloretos/metabolismo , Mucosa Intestinal/metabolismo , Transporte Biológico/efeitos dos fármacos , Cálcio/análise , Cálcio/fisiologia , Linhagem Celular , Quelantes/farmacologia , Colo , AMP Cíclico/análise , AMP Cíclico/fisiologia , GMP Cíclico/análise , GMP Cíclico/fisiologia , Citosol , Epitélio/efeitos dos fármacos , Epitélio/metabolismo , Humanos , Mucosa Intestinal/efeitos dos fármacos , Sistemas do Segundo Mensageiro , Ácido Taurocólico/farmacologia , Ácido Taurodesoxicólico/farmacologia
14.
Am J Physiol ; 256(6 Pt 1): C1224-30, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2472069

RESUMO

Free cytosolic Ca2+ [( Ca2+]i) has been implicated as a second messenger mediating the ion transport effects of carbachol, histamine, taurodeoxycholate, ionomycin, and 4-bromo-A23187 (4-BrA23187) in T84-cells. In this study, we correlated short-circuit current (Isc, reflective of Cl- secretion) and [Ca2+]i responses in T84-cell monolayers stimulated by these agents to evaluate the role of [Ca2+]i in Cl- secretory responses. Time-course studies showed that the duration of [Ca2+]i and Isc responses did not correlate with one another. Isc responses were more prolonged than [Ca2+]i responses with carbachol and histamine (both derived [Ca2+]i partly from intracellular sources), less prolonged than [Ca2+]i with taurodeoxycholate, and continued to increase after [Ca2+]i stabilized with ionomycin and 4-BrA23187. Isc and [Ca2+]i responses to histamine and carbachol were additive. A comparison of the magnitude of [Ca2+]i and Isc responses in cells stimulated by different agonists showed that the change in [Ca2+]i accompanying equivalent Isc responses varied greatly, suggesting that secretagogues vary in their dependency on [Ca2+]i. These findings suggest the existence of multiple [Ca2+]i-mediated effector mechanisms or the existence of multiple mediators that augment or attenuate the action of [Ca2+]i.


Assuntos
Cálcio/fisiologia , Cloretos/fisiologia , Canais Iônicos/fisiologia , Proteínas de Membrana/fisiologia , Sistemas do Segundo Mensageiro , Carbacol/farmacologia , Linhagem Celular , Canais de Cloreto , Neoplasias do Colo , Citosol/metabolismo , Ácido Egtázico/farmacologia , Éteres/farmacologia , Histamina/farmacologia , Humanos , Canais Iônicos/efeitos dos fármacos , Ionomicina , Cinética
16.
Am J Physiol ; 256(1 Pt 1): C197-203, 1989 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2536228

RESUMO

Adenosine and its agonists, 5'-(N-ethylcarboxamido)adenosine and N6-(D-2-phenylisopropyl)-adenosine, induced a sustained increase in chloride secretion when added to either the apical or basolateral aspect of monolayers of the human colonic epithelial cell line T84. Secretion was induced with identical kinetics by addition to both sides, but apical addition was less potent. The rank order of potency of the agonists on either side was consistent with the presence of an adenosine A2-receptor, but the apical and basolateral receptors differed in both their ability to stimulate increases in adenosine 3',5'-cyclic monophosphate, and their susceptibility to down-modulation by chronic exposure to 5'-(N-ethylcarboxamido) adenosine in culture.


Assuntos
Adenosina/farmacologia , Cloretos/metabolismo , Colo/metabolismo , Adenosina/administração & dosagem , Adenosina/análogos & derivados , Adenosina-5'-(N-etilcarboxamida) , Linhagem Celular , Colo/efeitos dos fármacos , AMP Cíclico/biossíntese , Condutividade Elétrica , Epitélio/metabolismo , Humanos , Mucosa Intestinal/efeitos dos fármacos , Cinética , Fenilisopropiladenosina/administração & dosagem , Fenilisopropiladenosina/farmacologia
17.
J Clin Invest ; 82(2): 514-23, 1988 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2457034

RESUMO

Escherichia coli heat stable enterotoxin (STa) caused Cl- secretion across T84 cell monolayers in a dose-dependent manner only when applied to the apical membrane surface and not when applied to the basolateral surface. Measurement of cAMP, cGMP, and free cytosolic Ca2+ in response to STa suggested that cGMP alone mediated the Cl- secretory response. Studies utilizing blockers of the Na+,K+-ATPase pump, a Na+,K+,Cl- cotransport system, a K+ channel, and a Cl- channel suggest that all of them participate in the Cl- secretory process induced by STa. The results suggest that the Cl- secretory response induced by STa is mediated by cGMP after the enterotoxin binds to its receptor on the apical membrane. The enterotoxin, by increasing cGMP, opens a K+ channel on the basolateral membrane as well as a Cl- channel on the apical membrane. The activation of these ion exit mechanisms, together with activations of the Na+,K+,Cl- cotransporter and the Na+,K+-ATPase pump drives Cl- exit through the Cl- channel on the apical membrane.


Assuntos
Toxinas Bacterianas/farmacologia , Permeabilidade da Membrana Celular/efeitos dos fármacos , Neoplasias do Colo/metabolismo , Enterotoxinas/farmacologia , Escherichia coli/fisiologia , Canais Iônicos/metabolismo , Membrana Basal/efeitos dos fármacos , Membrana Basal/metabolismo , Cálcio/metabolismo , Linhagem Celular , Cloretos/metabolismo , Neoplasias do Colo/microbiologia , AMP Cíclico/farmacologia , GMP Cíclico/metabolismo , Proteínas de Escherichia coli , Humanos , Canais Iônicos/efeitos dos fármacos , Potássio/metabolismo
18.
J Clin Gastroenterol ; 10(1): 57-63, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3282003

RESUMO

We review the use of antidiarrheal medications in inflammatory bowel disease, commenting on potential underlying immunologic mechanisms as a background for discussion of the clinical usage of antidiarrheal medications in this disease spectrum. We comment on new directions for the development of more effective therapeutic approaches and discuss the mechanism of action of antidiarrheal drugs, with emphasis on synthetic opiates.


Assuntos
Antidiarreicos/uso terapêutico , Colite Ulcerativa/tratamento farmacológico , Doença de Crohn/tratamento farmacológico , Antidiarreicos/farmacologia , Colite Ulcerativa/complicações , Colite Ulcerativa/imunologia , Doença de Crohn/complicações , Doença de Crohn/imunologia , Diarreia/tratamento farmacológico , Diarreia/etiologia , Humanos
20.
Am J Physiol ; 254(1 Pt 1): C53-62, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3337221

RESUMO

The mast cell mediator, histamine, induces a rapid and transient increase in chloride secretion across monolayers of the human colonic epithelial cell line, T84. Threshold stimulation occurred at 3 X 10(-6) M histamine and a maximal effect at 10(-4) M. The effect was reproduced by the H1 agonists 2-methylhistamine and 2-pyridylethylamine, but not by the H2 agonists 4-methylhistamine and dimaprit, suggesting the involvement of an H1 receptor. Additionally, histamine's action was inhibited by an H1 antagonist, diphenhydramine, but not by an H2 antagonist, cimetidine. Histamine treatment increased free cytosolic calcium levels, but not those of adenosine 3',5'-cyclic monophosphate (cAMP) or guanosine 3',5'-cyclic monophosphate (cGMP). The mechanism of chloride secretion induced by histamine resembled that of carbachol, in that both 1) were associated with an increase in free cytosolic calcium, 2) had a site of activation at a basolaterally localized K+ channel, and 3) were potentiated by both cAMP- and cGMP-mediated secretagogues. These results suggest that histamine may act as an intestinal secretagogue via direct interactions with epithelial cells.


Assuntos
Cloretos/metabolismo , Colo/metabolismo , Histamina/farmacologia , Sistema Imunitário/fisiologia , Mucosa Intestinal/metabolismo , Transporte Biológico/efeitos dos fármacos , Cálcio/metabolismo , Linhagem Celular , Colo/citologia , Citosol/metabolismo , Histamina/fisiologia , Antagonistas dos Receptores Histamínicos/farmacologia , Humanos , Mucosa Intestinal/citologia , Rubídio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA